FierceBiotech 2026年2月6日 Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk
FierceBiotech 2026年2月5日 Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA
FierceBiotech 2026年2月5日 Quell halts liver transplant Treg trial to focus on preclinical 'chill not kill' candidate
FierceBiotech 2026年2月5日 FDA’s rare pediatric disease voucher program revived by 2026 government funding bill
FierceBiotech 2026年2月4日 Lilly drops 3 pipeline drugs, including gene therapy, from $1B Prevail buyout